$34.19
1.665.1%
Last update: Nov 6, 5:38 PM
Maze Therapeutics Inc
MAZENASDAQ
The average analyst price target for Maze Therapeutics is $62.64, 80.6% above the current price. Of 11 analysts, 11 rate it Buy. Targets range from $28 to $110. The latest change came on Oct 19, 2026, when Canaccord Genuity initiated coverage of Maze Therapeutics with a Buy rating and a $75 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
